Core Viewpoint - P10, Inc. (PX) shows potential for significant upside, with a mean price target of $15.5 indicating a 46.5% increase from the current price of $10.58 [1] Price Targets and Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $3.79, indicating variability among analysts [2] - The lowest estimate of $13.00 suggests a 22.9% increase, while the highest estimate of $21.00 indicates a potential surge of 98.5% [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual price movements [7][10] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism regarding PX's earnings, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 0.7% over the past month, with no negative revisions [12] - PX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While consensus price targets may not be reliable for predicting the extent of PX's gains, they can provide a useful guide for the direction of price movement [14]

Universal Display Corp. (OLED) closed the last trading session at $146.75, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $183.86 indicates a 25.3% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $21.77. While the lowest estimate of $160.00 indicates a 9% increase from the current price level, the most optimisti ...

Group 1 - James Hardie (JHX) shares have increased by 8.5% over the past four weeks, closing at $21.36, with a mean price target of $27.17 indicating a potential upside of 27.2% [1] - The average price targets from analysts range from a low of $25.00 to a high of $30.00, with a standard deviation of $1.83, suggesting a potential increase of 17% to 40.5% from the current price [2] - Analysts have shown strong agreement in revising earnings estimates higher, with a 9.8% increase in the Zacks Consensus Estimate for the current year, indicating positive sentiment towards JHX's earnings prospects [11][12] Group 2 - JHX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets are often viewed as unreliable indicators, the direction implied by these targets suggests a positive outlook for JHX [14]

Core Viewpoint - CTO Realty (CTO) has shown a recent price increase of 2.2% and has a mean price target of $20.92, indicating a potential upside of 28.2% from its current trading price of $16.32 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $1.8, suggesting variability in analyst predictions. The lowest estimate is $18.50 (13.4% increase), while the highest is $23.00 (40.9% increase) [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about CTO's earnings prospects, as indicated by a positive trend in earnings estimate revisions. This trend has historically correlated with near-term stock price movements [11] - Over the past 30 days, one earnings estimate has increased, leading to a 0.6% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - CTO currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, which suggests a strong potential for upside [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Lexeo Therapeutics, Inc. (LXEO) has shown a significant price increase of 41.1% over the past four weeks, with a mean price target of $19.22 indicating a potential upside of 108.2% from its current price of $9.23 [1] Price Targets and Analyst Consensus - The average price target for LXEO is based on nine short-term estimates, ranging from a low of $9.00 to a high of $30.00, with a standard deviation of $6.57, indicating variability in analyst predictions [2] - The lowest estimate suggests a decline of 2.5%, while the highest points to a 225% upside, highlighting the range of opinions among analysts [2] - Analysts' price targets should be approached with caution, as empirical research indicates they often mislead investors rather than provide accurate guidance [7][10] Earnings Estimates and Analyst Agreement - There is a growing optimism among analysts regarding LXEO's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 4.1%, with two estimates moving higher and no negative revisions [12] - LXEO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a favorable outlook for the stock [13] Conclusion on Price Movement - While the consensus price target may not reliably indicate the extent of LXEO's potential gains, the direction implied by these targets appears to be a useful guide for investors [14]

Overview - Yahoo Finance explains the basics of Wall Street analyst notes, including earnings, ratings, and price targets [1] - Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, and advanced tools [1] Media & Content - Yahoo Finance's Stocks in Translation podcast releases new episodes every Tuesday and Thursday [1] - Yahoo Finance offers a variety of content including videos and articles on its website and app [1] Platforms & Access - The Yahoo Finance app is available on Apple and Android devices [1] - Yahoo Finance can be followed on social media platforms including X, Instagram, TikTok, Facebook, and LinkedIn [1]

Market Overview - Bitcoin reached a new all-time high above $126,000, surprising many traders [1] - The rally was unexpected due to previous failures at new highs, where sell-offs occurred [6] - A short squeeze liquidated over $923 million in short positions, fueling the price surge [7] Key Drivers - Spot Bitcoin ETFs were the primary driver, with over $5 billion inflows in the first week of October [8] - BlackRock's iShares Bitcoin Trust (IBIT) absorbed nearly $1 billion in a single day [8] - Macro catalysts included US government shutdown and expectations of Federal Reserve interest rate cuts [9] On-Chain Analysis - Bitcoin balance on centralized exchanges fell to 283% million BTC, the lowest since June 2019, creating a supply crunch [12] - Approximately 64% of Bitcoin has been held for over a year, indicating long-term holders are not selling [13] - MVRV z-score suggests Bitcoin is not yet in a state of mass euphoria, indicating room for growth [15] Institutional Price Targets - Wall Street consensus average sits around $156,000 for year-end 2025 [18] - Standard Chartered reaffirmed its $200,000 year-end 2025 price target, expecting $20 billion in ETF inflows [19][20] - JP Morgan estimates Bitcoin could climb to $165,000 based on a volatility-adjusted comparison with gold [20] Potential Risks - Macroeconomic risks, particularly a Federal Reserve policy reversal, could derail the rally [25] - High leverage in Bitcoin futures, with over $88 billion in open interest, makes the market vulnerable to liquidations [26] - Geopolitical risks could introduce extreme volatility [27]

Core Insights - The article emphasizes the importance of reliable information sources for investors, highlighting that historical performance does not guarantee future success [1][2] Group 1 - The information provided is intended for educational purposes and should not be considered as an offer or recommendation to buy or sell securities [1] - The data is sourced from reliable entities, but there is no guarantee regarding its accuracy or timeliness [1] - The ownership and estimate data are provided by LSEG and FactSet, respectively, indicating a reliance on established financial data providers [2]

Core Viewpoint - Intellia Therapeutics, Inc. (NTLA) has shown significant stock price appreciation of 72.1% over the past four weeks, with a mean price target of $33.46 indicating a potential upside of 63.7% from the current price of $20.44 [1] Price Targets and Analyst Estimates - The mean estimate consists of 24 short-term price targets with a standard deviation of $24.02, indicating variability among analysts. The lowest estimate is $8.00 (60.9% decline), while the highest is $106.00 (418.6% increase) [2] - Analysts' price targets can often mislead investors, as empirical research shows that these targets rarely indicate the actual price direction of a stock [7] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - Strong agreement among analysts in revising earnings per share (EPS) estimates higher supports the expectation of an upside for NTLA, as trends in earnings estimate revisions correlate with near-term stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.1%, with one estimate moving higher and no negative revisions [12] - NTLA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating potential upside in the near term [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of NTLA's potential gains, the implied direction of price movement appears to be a useful guide [14]

Citi's base case for Bitcoin over the next year is $181,000And $231,000 for the bull caseAre you really going to let the bankers be more bullish than you anon?matthew sigel, recovering CFA (@matthew_sigel):Citi introduces new 12-month price targets for digital assets:Bear Base BullBTC $82k $181k $231kETH $2k $5.4k $7.3k https://t.co/AlpWPaK2YW ...